<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:admin="http://webns.net/mvcb/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
	<channel>
<title>Mon Flux RSS</title><link>https://www.michel-lewin.be/index.html</link><description>Scoop&#x21;</description><dc:language>(null)</dc:language><language>(null)</language><dc:creator>user@domain.com</dc:creator><dc:rights>Copyright 2011 Michel Lewin</dc:rights><dc:date>2025-06-22T15:43:50+02:00</dc:date><admin:generatorAgent rdf:resource="http://www.realmacsoftware.com/" />
<admin:errorReportsTo rdf:resource="mailto:user@domain.com" /><sy:updatePeriod>hourly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>
<lastBuildDate>Sun, 11 Dec 2011 13:59:30 +0100</lastBuildDate><item><title>Principes Du Trt Des Leuc&#xe9;mies A&#xef;gues</title><dc:creator>user@domain.com</dc:creator><dc:subject>G&#xe9;n&#xe9;ralit&#xe9;s</dc:subject><dc:date>2025-06-22T15:43:50+02:00</dc:date><link>https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/185df0aee43c718814de0b43d3c4797a-15.html#unique-entry-id-15</link><guid isPermaLink="true">https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/185df0aee43c718814de0b43d3c4797a-15.html#unique-entry-id-15</guid><content:encoded><![CDATA[      ]]></content:encoded></item><item><title>Recommandations pour les principales tumeurs p&#xe9;dia</title><dc:creator>user@domain.com</dc:creator><dc:subject>G&#xe9;n&#xe9;ralit&#xe9;s</dc:subject><dc:date>2025-06-22T15:43:50+02:00</dc:date><link>https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/85fcd03ffef46bcef45f0c1e7fc7d1a3-16.html#unique-entry-id-16</link><guid isPermaLink="true">https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/85fcd03ffef46bcef45f0c1e7fc7d1a3-16.html#unique-entry-id-16</guid><content:encoded><![CDATA[      ]]></content:encoded></item><item><title>Epid&#xe9;miologie des cancers p&#xe9;dia</title><dc:creator>user@domain.com</dc:creator><dc:subject>G&#xe9;n&#xe9;ralit&#xe9;s</dc:subject><dc:date>2025-06-22T15:43:00+02:00</dc:date><link>https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/8e17ee7cadb1162cdad0d0c58bd0a5f5-19.html#unique-entry-id-19</link><guid isPermaLink="true">https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/8e17ee7cadb1162cdad0d0c58bd0a5f5-19.html#unique-entry-id-19</guid><content:encoded><![CDATA[      ]]></content:encoded></item><item><title>Ph&#xe9;ochromocytome</title><dc:creator>user@domain.com</dc:creator><dc:subject>G&#xe9;n&#xe9;ralit&#xe9;s</dc:subject><dc:date>2025-06-21T10:35:16+02:00</dc:date><link>https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/80dc81a3dcecd7c738899c086c073d84-21.html#unique-entry-id-21</link><guid isPermaLink="true">https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/80dc81a3dcecd7c738899c086c073d84-21.html#unique-entry-id-21</guid><content:encoded><![CDATA[      ]]></content:encoded></item><item><title>Paragangliome</title><dc:creator>user@domain.com</dc:creator><dc:subject>G&#xe9;n&#xe9;ralit&#xe9;s</dc:subject><dc:date>2025-06-21T10:34:36+02:00</dc:date><link>https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/02094100c5d96e779bb289a9cbb55ced-20.html#unique-entry-id-20</link><guid isPermaLink="true">https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/02094100c5d96e779bb289a9cbb55ced-20.html#unique-entry-id-20</guid><content:encoded><![CDATA[      ]]></content:encoded></item><item><title>Triade de Carney </title><dc:creator>user@domain.com</dc:creator><dc:subject>G&#xe9;n&#xe9;ralit&#xe9;s</dc:subject><dc:date>2025-06-21T10:12:11+02:00</dc:date><link>https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/755fc13e93477e4aff7a500d79626db7-22.html#unique-entry-id-22</link><guid isPermaLink="true">https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/755fc13e93477e4aff7a500d79626db7-22.html#unique-entry-id-22</guid><content:encoded><![CDATA[      ]]></content:encoded></item><item><title>DWI oncologique</title><dc:creator>user@domain.com</dc:creator><dc:subject>G&#xe9;n&#xe9;ralit&#xe9;s</dc:subject><dc:date>2025-06-20T10:52:49+02:00</dc:date><link>https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/1e5d7014c9ef31ab47e64a7dc022cada-18.html#unique-entry-id-18</link><guid isPermaLink="true">https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/1e5d7014c9ef31ab47e64a7dc022cada-18.html#unique-entry-id-18</guid><content:encoded><![CDATA[      ]]></content:encoded></item><item><title>Cancer de l&#x27;enfant : particularit&#xe9;s &#xe9;pid&#xe9;miologiques&#x2c; diagnostiques et th&#xe9;rapeutiques Introduction </title><dc:creator>user@domain.com</dc:creator><dc:subject>G&#xe9;n&#xe9;ralit&#xe9;s</dc:subject><dc:date>2025-06-09T11:20:59+02:00</dc:date><link>https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/2c3c4e36d4878ade41ce0f3fdd1f8c75-17.html#unique-entry-id-17</link><guid isPermaLink="true">https://www.michel-lewin.be/styled-12/styled-10/blog-48/files/2c3c4e36d4878ade41ce0f3fdd1f8c75-17.html#unique-entry-id-17</guid><content:encoded><![CDATA[      ]]></content:encoded></item></channel>
</rss>